The human immunodeficiency virus (HIV) is a disease worldwide with the increasing number of cases globally. Initially, HIV colliaiopati was often observed among these patients but has become rare after three decades due to the availability of new care choices and strong antiretroviral drugs. As a result, the incident now suggests drug resistance or the development of the disease. The relationship between Cholaghiocarcinoma and HIV is still unclear. We report cases of patients with high-grade dysplasia from Choledochus ducts and uncontrolled diseases treated with strong antivirus agents and dilated bile tract.

Learning points: HIV Choligiopathy must be remembered in HIV-positive patients even if they receive combination (train) antiretroviral therapy; Endoscopy Retrograde Choliaiopancreatography can provide symptomatic assistance. After HIV Chorangiopathy is detected, follow-up for Cholangiocarcinoma is needed. Corrected infections can cause choliaiocarcinoma in HIV-positive patients.

The decrease in the incidence of acute rejection without increasing the incidence of cytomegalovirus (CMV) infection in recipients of kidney transplants that accept the anti-thymocyte globulin (RATG) rabbit without prophylactic CMV

Induction therapy with the anti-thymocyte globulin (RATG) rabbit in recipients of low-risk ktridal transplants (KTR) remains controversial, given the increased risk of cytomegalovirus (CMV) infection. This natural experiment compares the clinical results of 12 months in low-risk KTR without CMV prophylaxis (Jan / 3/13-Sep / 16/15) accepting without induction or a single dose of 3mg / kg. We use logistic regression to characterize the pending graft function (DGF), negative binomials to characterize the length of hospitalization of hospitals (LOS) and Cox regression to characterize acute rejection (AR), CMV infection, mistrident of grafting, death and readmission.

The recipient received 3mg / kg Ratg had a risk of 81% lower than AR (AHR 0.14 0.190.25, p <0.001) but there was no increase in hospital admission due to infection (0.911.21, p = 0.5). There is no relationship between 3 mg / kg infection / CMV disease (AHR 0.86 1,101.40, p = 0.5), even when analysis is grouped based on the positive CMV serostatatus (AHR 0.94 1.25 1.65, p = 0, 15) and negative (AHR 0.28 0.57 1.16, p = 0.1). There is no relationship between 3MG / kg Ratg and mortality (AHR 0.51 1,253.08, p = 0.6), loss of grafts (AHR 0.34 0.731.55, p = 0.4). Among the low-risk ktr that does not accept the pharmacological prophylaxis of CMV, induction of 3mg / kg Ratg is associated with a significant reduction in the incidence of AR without an increased risk of CMV infection, regardless of the pre-transplant receiver CMV serostatus.

Lesions such as Degos as a skin manifestation of Cytomegalovirus infection: rare and serious complications in patients with drug induced hypersensitivity syndrome

Cytomegalovirus causes a myriad of clinical features, potentially influencing any organ system, significantly increases morbidity and even mortality. Vascular endothelial cell infections by CyTomeGalovirus have been involved in the development of Vasculopathy, perhaps accounting for clinical relations between Cytomegalovirus and vascular thrombosis. Unlike the involvement of visceral organs, cytomegalovirus skin manifestations varies and are rarely explained. Papulosis of malignant atrophy, which is commonly known as a Degos disease, is an unusual arteriopathic ship with a patognomonic clinical appearance from the middle porcelain-white papules surrounded by erythema Telangiectatic.

Like the arterial occlusive process, Degos may be idiopathic or secondary to autoimmune disorders or viral infections. All in all, presentations such as Degos related to Cytomegalovirus have never been explained. This report illustrates cases where disseminated cytomegalovirus disease is developed 4 weeks after the emergence of hypersensitivity syndrome induced by drugs with skin lesions such as prominent degos. Our case highlights a rare example of lesions such as Degos that occur because of cytomegalovirus disease and emphasizes the importance of early recognition of skin eruption characteristics as a diagnostic instrument that leads to the management of this life-threatening infection.

Cytomegalovirus pancreatitis in immunocompetent patients

Cytomegalovirus (CMV) is a DNA virus whose double strand, which infects most of the adult population. In immunocompetent patients, usually asymptomatic or manifest as symptoms of mild flu and self-limit, while in immunocompromised patients, CMV can cause significant disease. Here we report cases of unusual CMV pancreatitis in the 75-year-old woman’s immunocompetent. Patients develop severe significant pancreatic necrosis that failed non-operative management, and ultimately underwent the Pancreatic Necrosectomy. Then, he developed three spontaneous gastric perforations.

The first two perforations were managed operatively, but after the third perforation family decided not to undergo other operations. The diagnosis of CMV pancreatitis is based on pancreatic histopathology and confirms with a rapid response to Ganciclovir. The patient immediately began at Ganciclovir Intravenous (IV) which resulted in clinical recovery and he remained without symptoms of more than one year post op. This is a rare case of CMV pancreatitis with gastric perforation in immunocompetent patients. The level of suspicion is high and the right maintenance is important for such a clinical scenario.

Microvascular and structural abnormalities extralesional in cytomegalovirus retinitis

To evaluate extraesional microvascular and structural changes from the macula using Optical Coherence Tomography Angiography (Octa) and Structural October in the Citomegalovirus Retinitis (CMVR). A CMVR patient observational study was conducted. Complete ophthalmic examination, serial color fundus fundus, structural October and Octa are carried out at the beginning and follow-up visits up to 12 months. The structural OCT was analyzed to evaluate the macular area inside, bordering and exceed CMVR lesions.

Plexus extraledional retina capillaries from maculas are evaluated with October angiography and compared to fellow eyes that are not affected. Thirteen eyes from 13 registered patients. On the basis, the macular area without CMVR lesions showed a decrease in ship density (VD) of both superficial (p = 0,0002) and inside (p <0.0001) the retinal capillary plexus in the eye with CMVR compared to the area of ​​the macular not affected by fellow eyes that are not affected. The decrease in VD survives through the follow-up period of up to 12 months after adjusting the degree of vitreous fog.

TTC9B rabbit pAb
E44H14293	EnoGene	100ul	EUR 255
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

TTC9B rabbit pAb
UB-GEN-10081	UpingBio	100 ul	EUR 200

TTC39B (C-term) rabbit polyclonal antibody, Aff - Purified
AP54399PU-N	Origene Technologies GmbH	400 µl	Ask for price

TTC39B
CSB-CL713348HU	Cusabio	10 μg plasmid + 200μl Glycerol	Ask for price

TTC39B
MBS8561883-01mLAF405L	MyBiosource	0.1mL(AF405L)	EUR 565

TTC39B
MBS8561883-01mLAF405S	MyBiosource	0.1mL(AF405S)	EUR 565

TTC39B
MBS8561883-01mLAF610	MyBiosource	0.1mL(AF610)	EUR 565

TTC39B
MBS8561883-01mLAF635	MyBiosource	0.1mL(AF635)	EUR 565

TTC39B
MBS8561883-02mL	MyBiosource	0.2mL	EUR 345

TTC39B Antibody
1-CSB-PA713348LA01HU	Cusabio	Ask for price Ask for price	100ul 50ul
Description: A polyclonal antibody against TTC39B. Recognizes TTC39B from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB; Recommended dilution: WB:1:500-1:5000

TTC39B Antibody
DF14997	Affbiotech	100ul	EUR 420

TTC39B Antibody
DF14997-100ul	Affinity Biosciences	100ul	EUR 168
Description: IHC,IF/ICC,ELISA(peptide)

TTC39B Antibody
DF14997-200ul	Affinity Biosciences	200ul	EUR 210
Description: IHC,IF/ICC,ELISA(peptide)

TTC39B Antibody
E309527	EnoGene	200ul	EUR 275
Description: Available in various conjugation types.

TTC39B Antibody
GWB-MW659B	GenWay Biotech	50ug	Ask for price

TTC39B Antibody
MBS7113986-005mL	MyBiosource	0.05mL	EUR 190

TTC39B Antibody
MBS7113986-01mL	MyBiosource	0.1mL	EUR 270

TTC39B Antibody
MBS7113986-5x01mL	MyBiosource	5x0.1mL	EUR 1205

TTC39B Antibody
MBS9630285-01mL	MyBiosource	0.1mL	EUR 260

TTC39B Antibody
MBS9630285-02mL	MyBiosource	0.2mL	EUR 305

TTC39B Antibody
MBS9630285-5x02mL	MyBiosource	5x0.2mL	EUR 1220

TTC39B Antibody
MBS9632668-1mg	MyBiosource	1mg	EUR 375

TTC39B Antibody
MBS9632668-5x1mg	MyBiosource	5x1mg	EUR 1545

TTC39B, CT (TTC39B, C9orf52, Tetratricopeptide repeat protein 39B)
MBS645094-02mL	MyBiosource	0.2mL	EUR 695

TTC39B, CT (TTC39B, C9orf52, Tetratricopeptide repeat protein 39B)
MBS645094-5x02mL	MyBiosource	5x0.2mL	EUR 2975

Rat TTC39B siRNA
20-abx938469	Abbexa	Ask for price Ask for price	15 nmol 30 nmol

TTC39B siRNA (Rat)
MBS8212375-15nmol	MyBiosource	15nmol	EUR 405

TTC39B siRNA (Rat)
MBS8212375-30nmol	MyBiosource	30nmol	EUR 565

TTC39B siRNA (Rat)
MBS8212375-5x30nmol	MyBiosource	5x30nmol	EUR 2450

TTC39B, CT (TTC39B, C9orf52, Tetratricopeptide repeat protein 39B) (AP)
MBS6359947-02mL	MyBiosource	0.2mL	EUR 980

TTC39B, CT (TTC39B, C9orf52, Tetratricopeptide repeat protein 39B) (AP)
MBS6359947-5x02mL	MyBiosource	5x0.2mL	EUR 4250

TTC39B, CT (TTC39B, C9orf52, Tetratricopeptide repeat protein 39B) (PE)
MBS6359957-02mL	MyBiosource	0.2mL	EUR 980

TTC39B, CT (TTC39B, C9orf52, Tetratricopeptide repeat protein 39B) (PE)
MBS6359957-5x02mL	MyBiosource	5x0.2mL	EUR 4250

TTC39B cDNA Clone
MBS1276545-001mgPlasmid02mLGlycerolStock	MyBiosource	0.01mgPlasmid+0.2mLGlycerol-Stock	EUR 240

TTC39B cDNA Clone
MBS1276545-5x001mgPlasmid5x02mLGlycerolStock	MyBiosource	5x0.01mgPlasmid+5x0.2mLGlycerol-Stock	EUR 1030

TTC39B, CT (TTC39B, C9orf52, Tetratricopeptide repeat protein 39B) (APC)
MBS6359948-02mL	MyBiosource	0.2mL	EUR 980

TTC39B, CT (TTC39B, C9orf52, Tetratricopeptide repeat protein 39B) (APC)
MBS6359948-5x02mL	MyBiosource	5x0.2mL	EUR 4250

TTC39B, CT (TTC39B, C9orf52, Tetratricopeptide repeat protein 39B) (FITC)
MBS6359950-02mL	MyBiosource	0.2mL	EUR 980

TTC39B, CT (TTC39B, C9orf52, Tetratricopeptide repeat protein 39B) (FITC)
MBS6359950-5x02mL	MyBiosource	5x0.2mL	EUR 4250

Human TTC39B siRNA
20-abx905851	Abbexa	Ask for price Ask for price	15 nmol 30 nmol

Mouse TTC39B siRNA
20-abx938470	Abbexa	Ask for price Ask for price	15 nmol 30 nmol

TTC39B siRNA (Mouse)
MBS8227271-15nmol	MyBiosource	15nmol	EUR 405

TTC39B siRNA (Mouse)
MBS8227271-30nmol	MyBiosource	30nmol	EUR 565

TTC39B siRNA (Mouse)
MBS8227271-5x30nmol	MyBiosource	5x30nmol	EUR 2450

TTC39B siRNA (Human)
MBS8213325-15nmol	MyBiosource	15nmol	EUR 405

TTC39B siRNA (Human)
MBS8213325-30nmol	MyBiosource	30nmol	EUR 565

TTC39B siRNA (Human)
MBS8213325-5x30nmol	MyBiosource	5x30nmol	EUR 2450

TTC39B, CT (TTC39B, C9orf52, Tetratricopeptide repeat protein 39B) (Biotin)
MBS6359949-02mL	MyBiosource	0.2mL	EUR 980

TTC39B, CT (TTC39B, C9orf52, Tetratricopeptide repeat protein 39B) (Biotin)
MBS6359949-5x02mL	MyBiosource	5x0.2mL	EUR 4250

Ttc39b (untagged) - Mouse tetratricopeptide repeat domain 39B (Ttc39b), (10ug)
MC219732	Origene Technologies GmbH	10 µg	Ask for price

anti- TTC39B antibody
FNab09086	FN Test	100µg	EUR 658.5
Description: Antibody raised against TTC39B

TTC39B cloning plasmid
CSB-CL713348HU-10ug	Cusabio	10ug	EUR 333.6
Description: A cloning plasmid for the TTC39B gene.

TTC29 rabbit pAb
E28PN4188	EnoGene	100μl	EUR 255
Description: Available in various conjugation types.

TTC18 rabbit pAb
E28PN4301	EnoGene	100μl	EUR 255
Description: Available in various conjugation types.

TTC31 rabbit pAb
E28PN4440	EnoGene	100μl	EUR 255
Description: Available in various conjugation types.

TTC16 rabbit pAb
E28PN4962	EnoGene	100μl	EUR 255
Description: Available in various conjugation types.

TTC33 rabbit pAb
E28PT6804	EnoGene	100μl	EUR 255
Description: Available in various conjugation types.

TTC12 rabbit pAb
E28PT7166	EnoGene	100μl	EUR 255
Description: Available in various conjugation types.

TTC27 rabbit pAb
E28PT7291	EnoGene	100μl	EUR 255
Description: Available in various conjugation types.

TTC34 rabbit pAb
E28PN3181	EnoGene	100μl	EUR 255
Description: Available in various conjugation types.

TTC22 rabbit pAb
E28PN3215	EnoGene	100μl	EUR 255
Description: Available in various conjugation types.

TTC14 rabbit pAb
E28PN3380	EnoGene	100μl	EUR 255
Description: Available in various conjugation types.

TTC34 rabbit pAb
E44H12065	EnoGene	100ul	EUR 255
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

TTC22 rabbit pAb
E44H12099	EnoGene	100ul	EUR 255
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

TTC14 rabbit pAb
E44H12264	EnoGene	100ul	EUR 255
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

TTC29 rabbit pAb
E44H13072	EnoGene	100ul	EUR 255
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

TTC18 rabbit pAb
E44H13185	EnoGene	100ul	EUR 255
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

TTC31 rabbit pAb
E44H13324	EnoGene	100ul	EUR 255
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

TTC16 rabbit pAb
E44H13846	EnoGene	100ul	EUR 255
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

TTC33 rabbit pAb
E44H15357	EnoGene	100ul	EUR 255
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

TTC12 rabbit pAb
E44H15720	EnoGene	100ul	EUR 255
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

TTC27 rabbit pAb
E44H15845	EnoGene	100ul	EUR 255
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

TTC33 Rabbit pAb
E2612969	EnoGene	100ul	EUR 225
Description: Available in various conjugation types.

TTC33 Rabbit pAb
MBS8552513-01mL	MyBiosource	0.1mL	EUR 305

TTC33 Rabbit pAb
MBS8552513-01mLAF405L	MyBiosource	0.1mL(AF405L)	EUR 565

TTC33 Rabbit pAb
MBS8552513-01mLAF405S	MyBiosource	0.1mL(AF405S)	EUR 565

TTC33 Rabbit pAb
MBS8552513-01mLAF610	MyBiosource	0.1mL(AF610)	EUR 565

TTC33 Rabbit pAb
MBS8552513-01mLAF635	MyBiosource	0.1mL(AF635)	EUR 565

TTC33 rabbit pAb
UB-GEN-11262	UpingBio	100 ul	EUR 200

TTC12 rabbit pAb
UB-GEN-11623	UpingBio	100 ul	EUR 200

TTC27 rabbit pAb
UB-GEN-11747	UpingBio	100 ul	EUR 200

TTC34 rabbit pAb
UB-GEN-7859	UpingBio	100 ul	EUR 200

TTC22 rabbit pAb
UB-GEN-7892	UpingBio	100 ul	EUR 200

TTC14 rabbit pAb
UB-GEN-8057	UpingBio	100 ul	EUR 200

TTC29 rabbit pAb
UB-GEN-8862	UpingBio	100 ul	EUR 200

TTC18 rabbit pAb
UB-GEN-8975	UpingBio	100 ul	EUR 200

TTC31 rabbit pAb
UB-GEN-9113	UpingBio	100 ul	EUR 200

TTC16 rabbit pAb
UB-GEN-9634	UpingBio	100 ul	EUR 200

TTC39B, CT (TTC39B, C9orf52, Tetratricopeptide repeat protein 39B) (MaxLight 405)
MBS6359952-01mL	MyBiosource	0.1mL	EUR 980

TTC39B, CT (TTC39B, C9orf52, Tetratricopeptide repeat protein 39B) (MaxLight 405)
MBS6359952-5x01mL	MyBiosource	5x0.1mL	EUR 4250

TTC39B, CT (TTC39B, C9orf52, Tetratricopeptide repeat protein 39B) (MaxLight 490)
MBS6359953-01mL	MyBiosource	0.1mL	EUR 980

TTC39B, CT (TTC39B, C9orf52, Tetratricopeptide repeat protein 39B) (MaxLight 490)
MBS6359953-5x01mL	MyBiosource	5x0.1mL	EUR 4250

TTC39B, CT (TTC39B, C9orf52, Tetratricopeptide repeat protein 39B) (MaxLight 550)
MBS6359954-01mL	MyBiosource	0.1mL	EUR 980

TTC39B, CT (TTC39B, C9orf52, Tetratricopeptide repeat protein 39B) (MaxLight 550)
MBS6359954-5x01mL	MyBiosource	5x0.1mL	EUR 4250

TTC39B, CT (TTC39B, C9orf52, Tetratricopeptide repeat protein 39B) (MaxLight 650)
MBS6359955-01mL	MyBiosource	0.1mL	EUR 980

TTC39B, CT (TTC39B, C9orf52, Tetratricopeptide repeat protein 39B) (MaxLight 650)
MBS6359955-5x01mL	MyBiosource	5x0.1mL	EUR 4250

TTC39B, CT (TTC39B, C9orf52, Tetratricopeptide repeat protein 39B) (MaxLight 750)
MBS6359956-01mL	MyBiosource	0.1mL	EUR 980

TTC39B, CT (TTC39B, C9orf52, Tetratricopeptide repeat protein 39B) (MaxLight 750)
MBS6359956-5x01mL	MyBiosource	5x0.1mL	EUR 4250

Ttc39b (Myc-DDK-tagged) - Mouse tetratricopeptide repeat domain 39B (Ttc39b)
MR218431	Origene Technologies GmbH	10 µg	Ask for price

Ttc39b (GFP-tagged) - Mouse tetratricopeptide repeat domain 39B (Ttc39b), (10ug)
MG218431	Origene Technologies GmbH	10 µg	Ask for price

Ttc39b (untagged ORF) - Rat tetratricopeptide repeat domain 39B (Ttc39b), (10 ug)
RN214806	Origene Technologies GmbH	10 µg	Ask for price

TTC39B (NM_001168339) Human Recombinant Protein
E45H33053M5	EnoGene	20 ug	EUR 785.42

TTC39B (NM_152574) Human Recombinant Protein
E45H34052M5	EnoGene	20 ug	EUR 785.42

TTC39B (NM_152574) Human Recombinant Protein
PROTQ5VTQ0	BosterBio	20ug	EUR 1249
Description: Recombinant protein of human tetratricopeptide repeat domain 39B (TTC39B)

TTC39B ELISA KIT|Human
EF003927	Lifescience Market	96 Tests	EUR 826.8

TTC39B, CT (TTC39B, C9orf52, Tetratricopeptide repeat protein 39B) (Azide free) (HRP)
MBS6359951-02mL	MyBiosource	0.2mL	EUR 980

TTC39B, CT (TTC39B, C9orf52, Tetratricopeptide repeat protein 39B) (Azide free) (HRP)
MBS6359951-5x02mL	MyBiosource	5x0.2mL	EUR 4250

Rat TTC39B shRNA Plasmid
20-abx988909	Abbexa	Ask for price Ask for price	150 µg 300 µg

TTC39B Antibody (C-term)
E45R03519G-1	EnoGene	100 ul	EUR 395

TTC39B Antibody (C-term)
E45R03519G-4	EnoGene	50 ul	EUR 295

TTC39B Antibody (C-term)
MBS9204565-008mL	MyBiosource	0.08mL	EUR 210

TTC39B Antibody (C-term)
MBS9204565-04mL	MyBiosource	0.4mL	EUR 430

TTC39B Antibody (C-term)
MBS9204565-5x04mL	MyBiosource	5x0.4mL	EUR 1910

TTC5 Rabbit pAb
A13232	Abclonal	1000μL	EUR 262.15

TTC5 Rabbit pAb
A13232-100ul	Abclonal	100 ul	EUR 369.6

TTC5 Rabbit pAb
A13232-200ul	Abclonal	200 ul	EUR 550.8

TTC5 Rabbit pAb
A13232-20ul	Abclonal	20 ul	EUR 219.6

TTC5 Rabbit pAb
A13232-50ul	Abclonal	50 ul	EUR 267.6

TTC3 Rabbit pAb
A15734	Abclonal	1000μL	EUR 262.15

TTC3 Rabbit pAb
A15734-100ul	Abclonal	100 ul	EUR 369.6

TTC3 Rabbit pAb
A15734-200ul	Abclonal	200 ul	EUR 550.8

TTC3 Rabbit pAb
A15734-20ul	Abclonal	20 ul	EUR 219.6

TTC3 Rabbit pAb
A15734-50ul	Abclonal	50 ul	EUR 267.6

TTC3 Rabbit pAb
A21639	Abclonal	20μL	EUR 88.56

TTC1 Rabbit pAb
A8745	Abclonal	20μL	EUR 262.15

TTC1 Rabbit pAb
A8745-100ul	Abclonal	100 ul	EUR 369.6

TTC1 Rabbit pAb
A8745-200ul	Abclonal	200 ul	EUR 550.8

TTC1 Rabbit pAb
A8745-20ul	Abclonal	20 ul	EUR 219.6

TTC1 Rabbit pAb
A8745-50ul	Abclonal	50 ul	EUR 267.6

TTC8 Rabbit pAb
A5129-100ul	Abclonal	100 ul	EUR 369.6

TTC8 Rabbit pAb
A5129-200ul	Abclonal	200 ul	EUR 550.8

TTC8 Rabbit pAb
A5129-20ul	Abclonal	20 ul	Ask for price

TTC8 Rabbit pAb
A5129-50ul	Abclonal	50 ul	Ask for price

TTC5 rabbit pAb
E28PN3935	EnoGene	100μl	EUR 255
Description: Available in various conjugation types.

TTC6 rabbit pAb
E28PN4426	EnoGene	100μl	EUR 255
Description: Available in various conjugation types.

TTC8 Rabbit pAb
E47R11510	EnoGene	100ul	EUR 295

TTC1 Rabbit pAb
E45R28425N	EnoGene	50 ul	EUR 297.75

TTC5 Rabbit pAb
E45R19831N	EnoGene	50 ul	EUR 297.75

TTC3 Rabbit pAb
E45R22308N	EnoGene	50 ul	EUR 297.75

TTC5 rabbit pAb
E44H12819	EnoGene	100ul	EUR 255
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

TTC6 rabbit pAb
E44H13310	EnoGene	100ul	EUR 255
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

TTC3 Rabbit pAb
E2515734	EnoGene	100ul	EUR 225
Description: Available in various conjugation types.

TTC3 Rabbit pAb
MBS8550045-01mL	MyBiosource	0.1mL	EUR 305

TTC3 Rabbit pAb
MBS8550045-01mLAF405L	MyBiosource	0.1mL(AF405L)	EUR 565

TTC3 Rabbit pAb
MBS8550045-01mLAF405S	MyBiosource	0.1mL(AF405S)	EUR 565

TTC3 Rabbit pAb
MBS8550045-01mLAF610	MyBiosource	0.1mL(AF610)	EUR 565

TTC3 Rabbit pAb
MBS8550045-01mLAF635	MyBiosource	0.1mL(AF635)	EUR 565

TTC3 Rabbit pAb
MBS9142100-002mL	MyBiosource	0.02mL	EUR 200

TTC3 Rabbit pAb
MBS9142100-005mL	MyBiosource	0.05mL	EUR 255

TTC3 Rabbit pAb
MBS9142100-01mL	MyBiosource	0.1mL	EUR 345

TTC3 Rabbit pAb
MBS9142100-02mL	MyBiosource	0.2mL	EUR 545

TTC3 Rabbit pAb
MBS9142100-5x02mL	MyBiosource	5x0.2mL	EUR 2265

TTC5 rabbit pAb
UB-GEN-8611	UpingBio	100 ul	EUR 200

TTC6 rabbit pAb
UB-GEN-9099	UpingBio	100 ul	EUR 200

Mouse TTC39B shRNA Plasmid
20-abx977074	Abbexa	Ask for price Ask for price	150 µg 300 µg

Human TTC39B shRNA Plasmid
20-abx965852	Abbexa	Ask for price Ask for price	150 µg 300 µg

TTC7A Rabbit pAb
A20595	Abclonal	20μL	EUR 623.48

TTC9C rabbit pAb
E28PN4682	EnoGene	100μl	EUR 255
Description: Available in various conjugation types.

TTC7A Rabbit pAb
E45R29004N	EnoGene	50 ul	EUR 297.75

TTC9C rabbit pAb
E44H13566	EnoGene	100ul	EUR 255
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

TTC7A Rabbit pAb
MBS9143747-002mL	MyBiosource	0.02mL	EUR 200

TTC7A Rabbit pAb
MBS9143747-005mL	MyBiosource	0.05mL	EUR 255

TTC7A Rabbit pAb
MBS9143747-01mL	MyBiosource	0.1mL	EUR 345

TTC7A Rabbit pAb
MBS9143747-02mL	MyBiosource	0.2mL	EUR 545

TTC7A Rabbit pAb
MBS9143747-5x02mL	MyBiosource	5x0.2mL	EUR 2265

TTC9C rabbit pAb
UB-GEN-9355	UpingBio	100 ul	EUR 200

Macular structural characteristics on the limits and outside the lesions include intrarinal hyperreflective points, macular sistoid edema, subretinal fluid and loss of ellipsoid zone (EZ). Selective EZ losses found in 6 of 12 eyes showed recovery in 4 eyes after receiving anti-virus treatment. In the eye of CMVR, there are microvascular abnormalities and microstructure in the macular area without cmvr lesions that are clinically seen. Our results provide interesting insights into Retina CMV infection.